FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method of treating squamous cell carcinoma of the oral cavity and pharynx, involving a radiation therapy. From 1st to 35th day, a radiation therapy with a single focal dose of 2 Gy is performed daily for 5-day work week to a total focal dose of 50 Gy per a locoregional region, including regional lymphocytes CTV2/PTV2. Every day for following 3 days, additional GTV/CTV1/PTV1 tumor exposure is performed with a single focal dose of 6 Gy to a total focal dose of 68 Gy.
EFFECT: technical result consists in higher clinical effectiveness ensured by a greater degree of primary tumor regression and suppression of subclinical disseminated metastases.
1 cl, 2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX IN COMBINATION WITH RADIATION AND DRUG EXPOSURE | 2019 |
|
RU2705109C2 |
| METHOD FOR TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2018 |
|
RU2689875C2 |
| METHOD OF ORGAN-PRESERVING TREATMENT OF SQUAMOUS CELL CARCINOMA OF ORAL MUCOSA cT1N0M0 WITH DEPTH OF TUMOUR INVASION UP TO 5 mm | 2023 |
|
RU2824427C2 |
| METHOD FOR TREATMENT OF SQUAMOUS CELL P-16 POSITIVE OROPHARYNGEAL CANCER | 2020 |
|
RU2751818C2 |
| METHOD OF TREATMENT OF LOCALLY ADVANCED SQUAMOUS CELL CANCER OF ANAL CANAL | 2023 |
|
RU2809447C2 |
| METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER IIB-IIIB (T2B-T3BN0(1)M0) STAGES | 2020 |
|
RU2748135C2 |
| METHOD OF TREATING INITIAL STAGES OF ORAL CANCER | 2019 |
|
RU2713940C1 |
| MEDICAL UNIVERSAL APPLICATION SYSTEMS FOR CONTACT RADIATION THERAPY (BRACHYTHERAPY) OF MALIGNANT TUMOURS OF VARIOUS LOCALIZATION | 2022 |
|
RU2824293C2 |
| METHOD OF TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2010 |
|
RU2429032C1 |
| METHOD FOR PREDICTION OF FIVE-YEAR SURVIVAL RATE OF PATIENTS IN SURGICAL MANAGEMENT OF RECURRENT NON-GENERALIZED RESECTABLE ORAL CANCER | 2024 |
|
RU2823470C2 |
